![Hardy Kagimoto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hardy Kagimoto
Gründer bei
HEALIOS K.K.
Vermögen: 382 Mio $ am 31.05.2026
Profil
Hardy T.
S.
Kagimoto was the founder of PowerX, Inc. (founded in 2021) serving as Chairman; Healios KK (founded in 2011) serving as President, CEO & Representative Director; and Aqumen Biopharmaceuticals KK (founded in 2005) serving as Chairman, President & Chief Executive Officer.
Current jobs include President & Representative Director at Kagimoto Holdings KK since 2011, Adviser at Saisei Ventures LLC, and President at Sighregen Co., Ltd. since 2014.
Former jobs include President & Director at Healios N.A., Inc. and Director at Athersys, Inc. from 2018 to 2022.
Education includes a doctorate from Kyushu University conferred in 2002.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
POWERX, INC. 11,68 % | 21.01.2026 | 13.368.000 ( 11,68 % ) | 324 Mio $ | 31.05.2026 |
HEALIOS KK 20,61 % | 31.12.2025 | 27.830.300 ( 20,61 % ) | 59 Mio $ | 31.05.2026 |
Aktive Positionen von Hardy Kagimoto
| Unternehmen | Position | Beginn |
|---|---|---|
| HEALIOS K.K. | Gründer | 24.02.2011 |
| POWERX,INC. | Gründer | 22.03.2021 |
Kagimoto Holdings KK | Präsident | 01.11.2011 |
Sighregen Co., Ltd. | Präsident | 01.02.2014 |
Saisei Ventures LLC
 Saisei Ventures LLC Investment ManagersFinance Saisei Ventures invests in companies located across the globe. The firm focuses on the biotechnology sector with a focus on advanced therapies such as cell and gene therapies and regenerative medicines. It participates in seed and early stage transactions. | Berater | - |
Ehemalige bekannte Positionen von Hardy Kagimoto
| Unternehmen | Position | Ende |
|---|---|---|
| ATHERSYS, INC. | Direktor/Vorstandsmitglied | 16.06.2022 |
Healios N.A., Inc. | Präsident | - |
Aqumen Biopharmaceuticals KK
 Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Develops and researches therapeutic medicines | Vorstandsvorsitzender | - |
Ausbildung von Hardy Kagimoto
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
19
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Kyushu University
 Kyushu University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Athersys, Inc.
 Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
Aqumen Biopharmaceuticals KK
Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Develops and researches therapeutic medicines | Health Technology |
Healios KK
 Healios KK Pharmaceuticals: MajorHealth Technology Engages in the research, development and manufacture of cell therapy and regenerative medicine products | Health Technology |
Kagimoto Holdings KK | |
Sighregen Co., Ltd. | |
Healios N.A., Inc. | |
Saisei Ventures LLC
Saisei Ventures LLC Investment ManagersFinance Saisei Ventures invests in companies located across the globe. The firm focuses on the biotechnology sector with a focus on advanced therapies such as cell and gene therapies and regenerative medicines. It participates in seed and early stage transactions. | Finance |
PowerX, Inc.
 PowerX, Inc. Electrical ProductsProducer Manufacturing Manufactures and sells batter energy storage systems & operates EV charging stations and provides power supply services | Producer Manufacturing |
